Answers are grounded in this paper and cite their sources.
Alzheimer’s disease is closely associated with the interaction and aggregation of amyloid-beta (Aβ) peptides at neuronal membranes. Here, we use atomistic molecular dynamics simulations to investigate how two Aβ-interacting molecules, AC0107 and bexarotene, modulate Aβ–membrane interactions in a cholesterol-enriched POPC bilayer, with and without an oscillating GHz electric field. Five simulation conditions were examined, and peptide structural stability, membrane ordering, mobility, hydrogen bonding, radial distribution, and mass-density profiles were analyzed. The results reveal distinct modes of action for the two molecules. AC0107 preferentially localizes near the membrane–peptide interface and increases peptide–membrane hydrogen bonding, consistent with a barrier-like mechanism at the membrane surface. In contrast, bexarotene preferentially associates with the peptide when combined with the electric field, reduces peptide–membrane hydrogen bonding, and produces a more pronounced decrease in peptide mobility. The electric field therefore modulates the effects of the two compounds in different ways, enhancing the membrane-protective behavior of bexarotene while altering the response of AC0107. Overall, the simulations provide molecular-level insight into how small-molecule localization and external electric fields can regulate Aβ–membrane interactions.
No takes yet. Share an insight, caveat, or question.
Salehi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: